NEXT
Sign in to follow

New Jersey Law Journal

Drug Makers Argue Against Marketing Depositions in OTC Tylenol MDL

Drug makers McNeil-PPC and Johnson & Johnson are arguing in federal court that plaintiffs alleging injuries from over-the-counter Tylenol should not be able to depose a corporate designee on Tylenol-brand marketing expenditures, public relations and market research.
2 minute read

New Jersey Law Journal

D.C. Circuit Finds Doctors' Alternative Treatment Violates FDA's Authority

Doctors who produced a mixture of patients' stem cells and an antibiotic as part an alternative treatment for orthopedic conditions like arthritis violated federal laws regulating the making of drugs and biological products, a federal appeals court has ruled.
2 minute read

New Jersey Law Journal

Pfizer Attacks Plaintiff Experts in Zoloft MDL

Drug maker Pfizer is seeking to exclude the testimony of four of the plaintiff experts in the Zoloft Multidistrict Litigation, in which plaintiffs allege the antidepressant caused birth defects in babies.
3 minute read

New Jersey Law Journal

Louisiana Supreme Court Reverses $330.7 Million Judgment Over Risperdal Marketing

The Louisiana Supreme Court rules that Johnson & Johnson's Janssen subsidiary doesn't owe $257.7 million for alleged misconduct in marketing the antipsychotic drug Risperdal as well as $73 million in attorney fees and court costs.
3 minute read

New Jersey Law Journal

Court: Work-Product Privilege Doesn't Shield Asbestos Bankruptcy Trust Claim Forms

A Rhode Island judge has ruled the attorney work-product privilege can't protect from discovery the claim forms an asbestos plaintiff filed with bankruptcy trusts.
2 minute read

New Jersey Law Journal

FDA To Finalize Social-Media Rules for Drug Industry

The federal Food and Drug Administration has circulated guidance for the pharmaceutical industry on marketing on social media and is seeking comment on it.
2 minute read

New Jersey Law Journal

Seventh Circuit Upholds $1 Million Pradaxa Discovery Sanction, Reverses Deposition Order

The Seventh Circuit has ruled, in litigation over the prescription blood-thinning drug Pradaxa, that the drug maker should not have been ordered to produce German-based employees for depositions in the United States as a discovery sanction.
3 minute read

New Jersey Law Journal

What Makes Biomet MDL Settlement Different

Some interesting things about the global settlement struck this week over Biomet hip replacements were highlighted in an interview with one of the lead attorneys.
3 minute read

New Jersey Law Journal

The Product Liability Dimension of Brand Protection

The silos between the practice areas of product liability and intellectual property need to come down, argues a lawyer living in China who leads investigations into counterfeit fashion items and automotive parts.
2 minute read

New Jersey Law Journal

Merck Settles NuvaRing Contraceptive Litigation for $100 Million

Drug maker Merck & Co. has agreed to settle federal lawsuits venued in the Eastern District of Missouri Mulitidistrict Litigation, coordinated state lawsuits in New Jersey Superior Court and cases in other courts for $100 million.
2 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Strong & Hanni Solves Storage Woes--Learn How You Can, Too

    Brought to you by Filevine

    Download Now

  • Meeting the Requirements of California's SB 553: Workplace Violence Prevention

    Brought to you by NAVEX Global

    Download Now

  • The Benefits of Outsourcing Beneficial Ownership Information Filing

    Brought to you by Wolters Kluwer

    Download Now

  • The Top 10 AI Use Cases in Private Equity

    Brought to you by Ontra

    Download Now